Humpa, Ian Carl T.
HRN: 12-68-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/02/2023
09/09/2023
IV
180mg
Q12
S/p Exlap Appendectomy
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes